# Andrei Iagaru,  MD

Professor

Nuclear Radiology

Stanford Hospital

Nuclear Medicine

300 Pasteur Drive, Rm H2230 MC 5281

Stanford, CA 94305

[Maps, Directions & Parking](/content/en/location/stanford-hospital.html#googlemap-title/index.html)

Phone: [(650) 723-4000](tel:+1650 7234000)

## Locations

[Stanford Hospital](/content/en/location/stanford-hospital.html)

Nuclear Medicine

300 Pasteur Drive, Rm H2230 MC 5281

Stanford, CA 94305

[Maps, Directions & Parking](/content/en/location/stanford-hospital.html#googlemap-title/index.html)

Phone : [(650) 723-4000](tel:(650) 723-4000)

## Services

[Nuclear Medicine](/content/en/services/nuclear-medicine.html)

[Radiology](/content/en/services/radiology.html)

## Work and Education

Professional Education

- Carol Davila University of Medicine, Bucharest, Romania, 2000

Residency

- University of Southern California Keck School of Medicine, Los Angeles, CA, 2005
- Stanford University Medical Center, Stanford, CA, 2006

Fellowship

- Stanford University Medical Center, Stanford, CA, 2007

Internship

- Graduate Hospital (Closed), Philadelphia, PA, 2004

Board Certifications

- Nuclear Medicine, American Board of Nuclear Medicine, 2006

## Publications

### 1. Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [177Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.

_Journal of nuclear medicine : official publication, Society of Nuclear Medicine_  Park, H. L., Kersting, D., Bergstrom, C. P., Khaki, A. R., Shah, J., Davidzon, G. A., Moradi, F., Fan, A., Shah, S. A., Grady, E., Srinivas, S., Iagaru, A., Song, H. 2026

#### Abstract
This article evaluates whether early same-day posttherapy whole-body SPECT/CT assessed using visual RECIP 1.0 is associated with overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) that is positive for prostate-specific membrane antigen (PSMA) and treated with [177Lu]Lu-PSMA-617.

#### View details for [DOI 10.2967/jnumed.126.272651](https://doi.org/10.2967/jnumed.126.272651)

### 2. Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

_European urology_ Fanti, S., Turco, F., Tombal, B., Walz, J., Hofman, M. S., Hadaschik, B., Emmett, L., Tilki, D., Pecoraro, G., Salfi, G., Attard, G., Beltran, H., Bjartell, A., Briganti, A., Burger, I. A., Castro, E., Cerci, J. J., Chiti, A., Cooperberg, M., Fizazi, K., Fossati, N., Gafita, A., Gallina, A., Goffin, K., Horvath, L. G., Hugosson, J., Iagaru, A., James, N. D., Kasivisvanathan, V., Koh, D. M., Kristiansen, G., Kumar, R., Lecouvet, F., Loeb, S., McKay, R. R., Morris, M. J., Murphy, D. G., Murthy, V., Naoun, N., Oprea-Lager, D. E., Ost, P., O'Sullivan, J., Padhani, A. R., Palapattu, G., Paone, G., Petralia, G., Roobol, M. J., Sartor, O. A., Sathekge, M., Schuster, D. M., Seibert, T. M., Spratt, D. E., Tempany, C., Tunariu, N., Vargas, H. A., Vogl, U. M., Wyatt, A. W., Zilli, T., Lin, H. M., Omlin, A., Gillessen, S., Herrmann, K. 2026

#### View details for [DOI 10.1016/j.eururo.2026.06.009](https://doi.org/10.1016/j.eururo.2026.06.009)

### 3. Is there a role for early SSTR-targeting PRRT in GEP-NET?

_European journal of nuclear medicine and molecular imaging_ Ricciardello, G., Celesti, G., Bauckneht, M., Burger, I. A., Iagaru, A., Arco, M., Curatolo, S., Pagano, B., Amato, E., Auditore, L., Fiorillo, L., Piras, A., Piscopo, L., Shariftabrizi, A., Berretta, M., Vinci, S. L., Minutoli, F., Laudicella, R. 2026

#### View details for [DOI 10.1007/s00259-026-07974-4](https://doi.org/10.1007/s00259-026-07974-4)

### 4. AcTFirst: A phase 3 trial of <SUP>225</SUP>Ac-PSMA-617 plus ARPI versus standard of care in adults with PSMA-positive metastatic castration-resistant prostate cancer.

#### View details for [DOI 10.1200/JCO.2026.44.16_suppl.TPS5134](https://doi.org/10.1200/JCO.2026.44.16_suppl.TPS5134)

### 5. Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.

_Journal of nuclear medicine : official publication, Society of Nuclear Medicine_ Mittra, E. S., Solnes, L. B., van der Veldt, A. A., Wong, J., Aloj, L., Heinrich, M. C., Chen, C. T., Rowe, S. P., Brabander, T., Pacey, S., Aimone, P., Pathak, D., Blumenstein, L., Liu, Y., Iagaru, A. 2025

#### View details for [DOI 10.2967/jnumed.125.270411](https://doi.org/10.2967/jnumed.125.270411)
